Cell Therapy

News

BlueRock clears key hurdle in Parkinson's stem cell trial

It's a case of so far, so good for BlueRock Therapeutics' first clinical trial of Parkinson's disease therapy bemdaneprocel, with no major safety issues reported after a y

News

Aspen taps tech firms for digital Parkinson's trial

Aspen Neuroscience is adding a digital dimension to a study of its experimental cell therapy for Parkinson's disease, with the help of tech companies Emerald Innovations a

News

BMS backs $255m round for contract cell maker Cellares

Cellares has just closed a major $255 million third-round financing that will be used to complete a highly automated facility in New Jersey for the production of cell ther

News

Astellas adds to cell therapy drive with Poseida deal

Astellas has added another programme to its growing cell therapy pipeline via an agreement with Poseida on an off-the-shelf CAR-T therapy for solid tumours.

News

Tenpoint raises $70m for vision loss therapies

UK-headquartered start-up Tenpoint Therapeutics has reeled in a commendable $70 million in first-round financing that will be used to develop its cell-based therapies for

News

FDA approves first cell therapy for type 1 diabetes

CellTrans has claimed the first FDA approval for a cell therapy used to treat type 1 diabetes, consisting of insulin-producing islet beta cells taken from deceased donors.

BlueRock clears key hurdle in Parkinson's stem cell trial

Aspen taps tech firms for digital Parkinson's trial

BMS backs $255m round for contract cell maker Cellares

Astellas adds to cell therapy drive with Poseida deal

Tenpoint raises $70m for vision loss therapies

FDA approves first cell therapy for type 1 diabetes

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Cell Therapy

Editor's Picks